Reduced sarcoplasmic reticulum Ca2+-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 7, 1999, Pages 1381-1389

  Gupta, Ramesh C ^a,b   Mishra, Sudhish ^a   Mishima, Takayuki ^a   Goldstein, Sidney ^a   Sabbah, Hani N ^a  

^a Henry Ford Heart/Vascular Institute   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Ca2+ ATPase; Calcium; Heart failure; Phospholamban; Sarcoplasmic reticulum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CALSEQUESTRIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MONOCLONAL ANTIBODY; PHOSPHOLAMBAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOG; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; MALE; MEMBRANE VESICLE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM;

EID: 0033166250     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0970     Document Type: Article

References (28)

1. Afzal N, Dhalla NS, 1992. Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol 262: H868-H874.
2. Arai M, Alpert NR, Maclennan DH, Barton P, PeriAsamy M, 1993. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469.
3. Ari M, Matsui H, Periasamy M, 1994. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74: 555-564.
4. Bohm M, Reiger B, Schwinger RHG, ERdmann E, 1994. Camp concentrations, camp-dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res 1981, 28: 1713-1719.
5. Brodde OE, Michel MC, Zerkowski HR, 1995. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovas Res 30: 570-584.
6. Burnette WN, 1981. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112: 195-203.
7. Cory CR, Grange RW, Houston ME, 1994. Role of sarcoplasmic reticulum in loss of load-sensitive relaxation in pressure overload cardiac hypertrophy. Am J Physiol 266: H68-H78.
8. 2+-ATPase activity and expression in ventricular myocardium of dogs with heart failure. Am J Physiol 273: H12-H18.
9. 2+] in intact human myocardium. Circulation 82: 1266-1278.
10. Hartzell HC, 1988. Regulation of cardiac ion channels by catecholamines, acetylcholine, and second messenger system. Prog Biophys Mol Biol 52: 165-247.
11. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434-442.
12. 2+-transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 77: 759-764.
13. 2+-transport by cyclic 3′,5′-AMO-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. Biochem Biophys Acta 844: 193-199.
14. 4. Nature 227: 680-685.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
16. Luo W, Grupp IL, Harrer J, Ponniah S, GRupp G, Duffy JJ, Doetschman T, Kranias EG, 1994. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75: 401-409.
17. Martonosi A, 1972. Biochemical and clinical aspects of sarcoplasmic reticulum function. In Current Topics in Membranes and Transport, Vol. 3 (Bronner F and Kleinzeller A eds), pp. 83-197. Academic Press, New York.
18. Morgan JP, 1991. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325: 625-632.
19. 2+-uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res 65: 1141-1144.
20. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657.
21. Mullieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR, 1992. Altered myocardial force-frequency relation in human heart failure. Circulation 85: 1743-1750.
22. 2+-accumulation in nonfailing and failing human myocardium. Circulation 92: 2504-2510.
23. Sabbah HN, Stein PD, Kono T, Gheorghiade TB, Levine S, Jafri S, Hawkins ET, Goldstein S, 1990. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 260: H1379-H1384.
24. Sabbah HN, Shimoyama T, Kono T, Gupta RC, Sharov G, Scicli G, Levine TB, Goldstein S, 1994. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 89: 2852-2859.
25. Sambrook J, Fritsch EF, Maniatis T, 1989. Molecular Cloning - A Laboratory Manual, 2nd Edition. Cold Spring Harbor Laboratory Press.
26. Schwinger RHG, Bohm M, ERdmann E, 1992. Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J 123: 116-128.
27. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228.
28. Whitmer JT, Pankaj K, Solaro RJ, 1988. Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic syrian hamsters (BIO 53.58 and 14.6): Evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts. Circ Res 62: 81-85.